| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/24/2005 | CN1658895A Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis |
| 08/24/2005 | CN1658893A G-type peptides to ameliorate atherosclerosis |
| 08/24/2005 | CN1658892A Method for isolating subpopulations of proteins that engage in protein-protein interactions |
| 08/24/2005 | CN1658763A Canola protein isolate compositions |
| 08/24/2005 | CN1657634A Process for preparing active lactoferritin |
| 08/24/2005 | CN1657627A Detection gene of Fasarium graminearum for resisting carbendazim and its detection method |
| 08/24/2005 | CN1657626A Antifungal polypeptide and its preparation method |
| 08/24/2005 | CN1657624A Wheat jasminic acid inducing protein, its coding gene and method for plant culturing |
| 08/24/2005 | CN1657619A Recombination human erythropoietin gene suitable for pronucleus expression system and its expression carrier |
| 08/24/2005 | CN1657618A Hepatic correlative oncogene inhibitory and use |
| 08/24/2005 | CN1657540A Polyethylene glycol derivative of human parathyrin (1-34), medicinal composition containing same and use |
| 08/24/2005 | CN1657539A Human connective tissue growth factor mutant protein and its application |
| 08/24/2005 | CN1657538A Tumour specific antigen TA48 and its application in cancer diagnosis |
| 08/24/2005 | CN1216149C Cell strain of expression mutation type human tissue plasminogen activator imethod for construction and preparation method of expressing protein |
| 08/24/2005 | CN1216075C Hepatitis C virus high change region 1 synthetic peptide and its use |
| 08/24/2005 | CN1215879C 人类sars冠状病毒受体抑制剂 Human sars coronavirus receptor inhibitors |
| 08/24/2005 | CA2497796A1 Fibrinogen purification |
| 08/23/2005 | US6933422 Nav2 channel gene-deficient mice |
| 08/23/2005 | US6933377 Compositions comprising multiple immunodeficiency virus subunits for inducing an immune response |
| 08/23/2005 | US6933376 Cell cycle polynucleotides, polypeptides and uses thereof |
| 08/23/2005 | US6933375 mcFP encoding nucleic acids, polypepetides, antibodies and methods of use thereof |
| 08/23/2005 | US6933373 Tumor suppressor protein for as a antiproliferative agent |
| 08/23/2005 | US6933370 Methods for purifying highly anionic proteins |
| 08/23/2005 | US6933366 Specificity exchangers that redirect antibodies to bacterial adhesion receptors |
| 08/23/2005 | US6933365 Mutant tyrosine repressor proteins |
| 08/23/2005 | US6933364 Secretory thyroid stimulating hormone receptor, and method for assaying anti-thyroid stimulating hormone receptor antibody using the same |
| 08/23/2005 | US6933363 Compositions and methods for therapy and diagnosis of lung cancer |
| 08/23/2005 | US6933362 Mutant intein made by combination of protein engineering and random mutagenesis that can be used in purification of proteins such as toxic proteins, by inactivation with the intein in a specific region and controllable splicing |
| 08/23/2005 | US6933352 Amphiphilic compounds having a dendritic branch structure |
| 08/23/2005 | US6933280 Peptides for the treatment of Alzheimer's disease and other beta-amyloid protein fibrillogenesis disorders |
| 08/23/2005 | US6933279 Peptides comprising a class A amphipathic helix when formulated with "D" amino acid residue(s) and/or having protected amino and carboxyl termini |
| 08/23/2005 | US6933276 Methods of treating peripheral neuropathies using neurotrophin-3 |
| 08/23/2005 | US6933274 Methods for treatment of diabetes using a peptide analogues of insulin |
| 08/23/2005 | US6933273 Nucleotide sequences coding polypeptide for use as wound healing agent |
| 08/23/2005 | US6933271 Aimed at neoplastic cells with gonadotropin releasing hormone binding sites; anticarcinogenic agents; genetically engineered Pseudomonas Exotoxin |
| 08/23/2005 | US6933150 Genetic transduction of cells with nucleic acid codes for transmembrane efflux pumps, gene expression and culturing, for use in bone marrow grafting and gene therapy |
| 08/23/2005 | US6933147 Human cyclic nucleotide-gated channel polypeptide |
| 08/23/2005 | US6933145 Materials and methods for delivery and expression of heterologous DNA in vertebrate cells |
| 08/23/2005 | US6933134 Heterodimeric vascular endothelial growth factor II in which the 2 subunits are encoded by different genes |
| 08/23/2005 | US6933133 Treatment of diabetes with synthetic beta cells |
| 08/23/2005 | US6933132 Regulation of immune responses by attractin |
| 08/23/2005 | US6933131 Nucleotide sequences for use in biological pest control; insecticides |
| 08/23/2005 | US6933130 Recombinants process for preparing a complete malaria antigen, gp190/MSP1 |
| 08/23/2005 | US6933127 Substrate for PP2C |
| 08/23/2005 | US6933125 Human c-Maf compositions and methods of use thereof |
| 08/23/2005 | US6933123 Peptides from the E2, E6, and E7 proteins of human papilloma viruses 16 and 18 for detecting and/or diagnosing cervical and other human papillomavirus associated cancers |
| 08/23/2005 | US6933118 Detection polymorphism of genes; testing using primer Dna; calibration |
| 08/23/2005 | US6933116 Nucleic acid ligand binding site identification |
| 08/23/2005 | US6933115 Nucleic acid molecules encoding GLUTX and uses thereof |
| 08/23/2005 | US6933114 Nucleotide sequence ligand for use in the detection diagnosis and treatment of cancer |
| 08/23/2005 | US6933113 Modulation of endogenous gene expression in cells |
| 08/23/2005 | US6933110 Trypanosoma cruzi antigen, gene encoding therefor and methods of detecting and treating chagas disease |
| 08/23/2005 | US6932973 Peptides which stimulate the expression of the cytokines of inflammation and promote tissue regeneration |
| 08/23/2005 | US6932972 Combined vaccine compositions |
| 08/23/2005 | US6932971 Nicotine-hapten composition for diagnosing, preventing and treating drug addiction; vaccine for treating nicotine addiction, palliating nicotine withdrawal, facilitating smoking cessation and/or preventing relapse |
| 08/23/2005 | US6932968 An anti-idiotype antibody against the binding region of an antibody directed against an EPO peptide, wherein said antibody neutralizes the bioactivity of EPO; diagnostic aids for the detection of EPO or of anti-EPO antibodies |
| 08/23/2005 | US6932965 Separation of deamidated and non-deamidated human dnases and use of the non-deamidated species as a pharmaceutical per se; administering to patients suffering from pulmonary distress |
| 08/23/2005 | CA2278396C Fish collagen and method of producing the same |
| 08/23/2005 | CA2267661C Variants of vascular endothelial cell growth factor having antagonistic properties |
| 08/23/2005 | CA2193122C Tetracycline-regulated transcriptional modulators |
| 08/23/2005 | CA2186044C Novel mutated viruses, anti-viral compounds and novel methods of making vaccines |
| 08/23/2005 | CA2142300C Methods for detecting alzheimer's disease |
| 08/23/2005 | CA2108000C Enhanced gene expression in plants using an hsp70 intron sequence |
| 08/23/2005 | CA2094464C Mutant respiratory syncytial virus (rsv) vaccines containing same and methods of use |
| 08/23/2005 | CA2094276C Antibodies against the urokinase receptor and their use |
| 08/23/2005 | CA2070281C Improved treatment of autoimmune diseases by aerosol administration of auto antigens |
| 08/18/2005 | WO2005076015A1 Taurine transporter tau1 expressed in blood brain barrier cells |
| 08/18/2005 | WO2005076013A2 Process for screening glycoform-specific antibodies |
| 08/18/2005 | WO2005076012A2 Novel splice variants and methods of use thereof |
| 08/18/2005 | WO2005076000A1 Method for assessing risk of and predisposition to development of a pathology related to the presence of anti-epcr autoantibodies |
| 08/18/2005 | WO2005075685A1 Genes associated with canine osteoarthritis and related methods and compositions |
| 08/18/2005 | WO2005075684A2 Use of organic anion transporter b in screens for candidate substrates for crossing the blood brain barrier |
| 08/18/2005 | WO2005075679A2 Antigenic hiv-1 peptides |
| 08/18/2005 | WO2005075677A2 Identification of compounds susceptible to induce pidd in cells lacking p53 and their use in combination with genotoxins for the treatment of cancer |
| 08/18/2005 | WO2005075672A1 Diagnostics and therapeutics for diseases associated with human cholecystokinin receptor b (cckbr) |
| 08/18/2005 | WO2005075660A1 Improved composition for cell-free protein synthesis |
| 08/18/2005 | WO2005075655A2 Ap2 domain transcription factor odp2 (ovule development protein 2) and methods of use |
| 08/18/2005 | WO2005075653A1 Cell surface expression vector of parvovirus antigen and microorganisms transformed thereof |
| 08/18/2005 | WO2005075648A1 Interleukin-18 mutant proteins |
| 08/18/2005 | WO2005075646A1 Peptide originating in stress-induced antiapoptosis molecule (iex-1) |
| 08/18/2005 | WO2005075645A1 Therapeutic molecules and methods for generating and/or selecting same |
| 08/18/2005 | WO2005075641A1 Screening method |
| 08/18/2005 | WO2005075640A1 Canine cd20 gene |
| 08/18/2005 | WO2005075631A1 Process for the preparation of l-amino acids with amplification of the zwf gene |
| 08/18/2005 | WO2005075626A1 MICROORGANISM PRODUCING L-THREONINE HAVING INACTIVATED tyrR GENE, METHOD OF PRODUCING THE SAME AND METHOD OF PRODUCING L-THREONINE USING THE MICROORGANISM |
| 08/18/2005 | WO2005075625A1 MICROORGANISM PRODUCING L-THREONINE HAVING INACTIVATED ga1R GENE, METHOD OF PRODUCING THE SAME AND METHOD OF PRODUCING L-THREONINE USING THE MICROORGANISM |
| 08/18/2005 | WO2005075513A1 Dj-1 derivative having acidified cysteine residue |
| 08/18/2005 | WO2005075512A1 Crystal structures and models for fc receptors and uses thereof in the design or identification of fc receptor modulator compounds |
| 08/18/2005 | WO2005075511A1 Variants of the extracellular domain of bcma and uses thereof |
| 08/18/2005 | WO2005075510A1 Diagnostics and therapeutics for diseases associated with potassium channel, subfamily k, member 9 (kcnk9) |
| 08/18/2005 | WO2005075509A1 Angiogenesis inhibitors, compositions containing same and use thereof for treating diseases related to angiogenetic deregulation |
| 08/18/2005 | WO2005075508A2 Hyperactive stat molecules and their use in assays employing gene activation |
| 08/18/2005 | WO2005075507A1 Amyloid beta peptide binding polypeptide |
| 08/18/2005 | WO2005075506A1 Identification of endogenous trimerization domains in the adenovirus fiber protein that allow detargeting and retargeting of viral vectors |
| 08/18/2005 | WO2005075500A1 Method for separating/refining cationic protein |
| 08/18/2005 | WO2005075448A2 A method for manufacturing optically pure coumaryl amino acids salts and the coumaryl amino acid salts thus obtained |
| 08/18/2005 | WO2005074985A2 Methods of modulating cd200 and cd200r |
| 08/18/2005 | WO2005074981A2 Inhibitors of tgf-r signaling for treatment of cns disorders |
| 08/18/2005 | WO2005074972A2 Treatment of conditions involving dopaminergic neuronal degeneration using nogo receptor antagonists |
| 08/18/2005 | WO2005074968A2 Medical use of basic peptides |